Health and Human Services News and Research

RSS

New combination treatment approved by FDA for metastatic pancreatic cancer

The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with gemcitabine-based chemotherapy.

23 Oct 2015

Scientists map out the brain circuitry critical for filtering out distractions

In a study of mice, scientists discovered that a brain region called the thalamus may be critical for filtering out distractions. The study, published in Nature and partially funded by the National Institutes of Health, paves the way to understanding how defects in the thalamus might underlie symptoms seen in patients with autism, attention deficit hyperactivity disorder (ADHD), and schizophrenia.

22 Oct 2015

Veltassa (patiromer for oral suspension) gets FDA approval for treatment of hyperkalemia

The U.S. Food and Drug Administration today approved Veltassa (patiromer for oral suspension) to treat hyperkalemia, a serious condition in which the amount of potassium in the blood is too high.

22 Oct 2015

Coagadex now approved by FDA for patients with hereditary Factor X deficiency

The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency. Until today's orphan drug approval, no specific coagulation factor replacement therapy was available for patients with hereditary Factor X deficiency.

21 Oct 2015

Team-based, coordinated specialty care approach produces better outcomes for people with first episode psychosis

New research shows that treating people with first episode psychosis with a team-based, coordinated specialty care approach produces better clinical and functional outcomes than typical community care. Investigators also found that treatment is most effective for people who receive care soon after psychotic symptoms begin.

20 Oct 2015

Chronic diseases in Bangladesh drag more households below poverty line

A new study published in the International Journal of Epidemiology shows that over the past decades Bangladesh observed a successful health transition while chronic diseases shifted from the rich to affect in excess also poor households.

20 Oct 2015

Genetic mutation linked to ALS, FTD prevents proteins from entering and exiting the cell's nucleus

Three teams of scientists supported by the National Institutes of Health showed that a genetic mutation linked to some forms of amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) may destroy neurons by disrupting the movement of materials in and out of the cell's nucleus, or command center where most of its DNA is stored.

19 Oct 2015

FDA grants accelerated approval to Praxbind (idarucizumab)

The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa's blood-thinning effects.

19 Oct 2015

Scientists use new technology to create gene expression map of inner ear cell development

Using a sensitive new technology called single-cell RNA-seq on cells from mice, scientists have created the first high-resolution gene expression map of the newborn mouse inner ear.

16 Oct 2015

Gene therapy preserves vision in canine model of late-stage retinitis pigmentosa

Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.

15 Oct 2015

Ebola virus can linger in semen of some men nine months after onset of symptoms

Preliminary results of a study into persistence of Ebola virus in body fluids show that some men still produce semen samples that test positive for Ebola virus nine months after onset of symptoms.

15 Oct 2015

Investigational antiviral drug effectively treats Lassa virus infection in guinea pigs

Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from National Institutes of Health scientists and colleagues.

13 Oct 2015

Harris Health System to help HHS improve critical cyber infrastructure of healthcare sector

Harris Health System is the only healthcare system in the nation awarded a $150,000 grant to help the U.S. Department of Health and Human Services (HHS) develop and improve ways to share cybersecurity threat information and protect the critical cyber infrastructure of the nation's public and private healthcare sector.

13 Oct 2015

Gensignia gets CLIA certification to establish clinical laboratory in San Diego

Gensignia Life Sciences, Inc. (Gensignia) announced today that it received certification under the Clinical Laboratory Improvement Amendments (CLIA).

13 Oct 2015

Study highlights need for dietary interventions in cancer survivors

While most cancer survivors in the United States are motivated to seek information about food choices and dietary changes to improve their health, a new study comparing their dietary patterns to federal guidelines indicates that they often fall short.

13 Oct 2015

Health and Human Services News and Research

New combination treatment approved by FDA for metastatic pancreatic cancer

Scientists map out the brain circuitry critical for filtering out distractions

Veltassa (patiromer for oral suspension) gets FDA approval for treatment of hyperkalemia

Coagadex now approved by FDA for patients with hereditary Factor X deficiency

Team-based, coordinated specialty care approach produces better outcomes for people with first episode psychosis

Chronic diseases in Bangladesh drag more households below poverty line

Genetic mutation linked to ALS, FTD prevents proteins from entering and exiting the cell's nucleus

FDA grants accelerated approval to Praxbind (idarucizumab)

Scientists use new technology to create gene expression map of inner ear cell development

Gene therapy preserves vision in canine model of late-stage retinitis pigmentosa

Ebola virus can linger in semen of some men nine months after onset of symptoms

Investigational antiviral drug effectively treats Lassa virus infection in guinea pigs

Harris Health System to help HHS improve critical cyber infrastructure of healthcare sector

Gensignia gets CLIA certification to establish clinical laboratory in San Diego

Study highlights need for dietary interventions in cancer survivors

FDA orders three duodenoscope manufacturers in the U.S. to conduct postmarket surveillance studies

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

Federal judge grants permanent injunction against South Dakota medical laser manufacturer

FDA approves Opdivo to treat patients with advanced non-small cell lung cancer

FDA awards research grants to boost product development for patients with rare diseases

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News